Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Eupraxia Pharmaceuticals Inc
EPRXCurrent price
4.25 CAD
+0.2 CAD (+4.94%)
Last closed
4 CAD
Company
www.eupraxiapharma.com
ISIN
CA29842P1053
Sector
Healthcare
Industry
Biotechnology
Exchange
Toronto Exchange
Capitalization
158 345 891 CAD
Yield for 12 month
-35.02 %
1Y
3Y
5Y
10Y
15Y
EPRX
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. Address: 2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17.41 CADP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-212 062 CAD
Last Year
-195 254 CAD
Current Quarter
-58 097 CAD
Last Quarter
-50 978 CAD
Key Figures EPRX
1 year
3 years
5 years
10 years
EBITDA
-32 088 722 CAD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-98.68 %
PEG Ratio
–
Return On Equity TTM
-314.41 %
Wall Street Target Price
17.41 CAD
Revenue TTM
–
Book Value
0.082 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.3 CAD
Diluted Eps TTM
-1.3 CAD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics EPRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EPRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation EPRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.8823
Price Book MRQ
7.62
Financials EPRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EPRX
For 52 weeks
3.1 CAD
7.72 CAD
50 Day MA
3.63 CAD
Shares Short Prior Month
11 735
200 Day MA
4.19 CAD
Short Ratio
0.72
Shares Short
15 902
Short Percent
0.07 %
BeatStart